Hormonal Contraceptives Global Market Report 2026

Description

Hormonal contraceptives are birth control methods that prevent pregnancy through the use of hormones. There are various types, some of which are reversible, while others are permanent. Certain forms can also help reduce the risk of STDs.

The main types of products include injectable birth control, emergency contraceptive pills, vaginal rings, and others. Oral contraceptive pills, or birth control pills, consist of synthetic steroid hormones that inhibit the release of follicle-stimulating hormone (FSH) and luteinizing hormone (LH) from the anterior pituitary in females. These pills contain different hormones, including progestin-only and combined hormones, and are used in hospitals, homecare settings, gynecology centers, clinics, and ambulatory surgical centers. They are distributed through channels such as drugstores, gynecology or fertility clinics, e-commerce platforms, and others.

Tariffs have influenced the hormonal contraceptives market by increasing the cost of imported raw materials, active pharmaceutical ingredients, and delivery devices, which has raised production costs for pills, injectable contraceptives, and hormonal implants. Asia-Pacific regions such as India and China, which are major manufacturers, are particularly affected, while hospitals and gynecology centers face higher procurement costs. However, tariffs are also encouraging local production and innovation, potentially reducing dependency on imports and fostering cost-efficient solutions in the long term.

The hormonal contraceptives market research report is one of a series of new reports from The Business Research Company that provides hormonal contraceptives market statistics, including hormonal contraceptives industry global market size, regional shares, competitors with a hormonal contraceptives market share, detailed hormonal contraceptives market segments, market trends and opportunities, and any further data you may need to thrive in the hormonal contraceptives industry. This hormonal contraceptives market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The hormonal contraceptives market size has grown marginally in recent years. It will grow from $14.4 billion in 2025 to $14.58 billion in 2026 at a compound annual growth rate (CAGR) of 1.2%. The growth in the historic period can be attributed to rising awareness of family planning, introduction of combined oral contraceptives, government initiatives for reproductive health, increasing urbanization, growth of gynecology clinics.

The hormonal contraceptives market size is expected to see steady growth in the next few years. It will grow to $15.82 billion in 2030 at a compound annual growth rate (CAGR) of 2.1%. The growth in the forecast period can be attributed to advancements in personalized hormone therapies, rise of male contraceptive products, expansion of e-commerce for contraceptives, integration of digital health platforms, increasing focus on STD prevention. Major trends in the forecast period include rise of hormone-based personalized contraceptives, increasing awareness of reversible and non-reversible options, growth in telemedicine and online contraceptive services, expansion of male contraceptive solutions, focus on contraceptives with dual protection against stds.

Growing awareness of hormonal contraceptives has led to a more informed and empowered population, enabling individuals to make choices that align with their reproductive goals and lifestyles. As people become more knowledgeable about available contraceptive options, they are better equipped to make decisions regarding their reproductive health, which in turn drives greater adoption of hormonal contraceptives suited to their family planning and lifestyle preferences. For example, in July 2025, according to the World Health Organization (WHO), a Switzerland-based specialized UN agency for international public health, 874 million women were using modern contraceptives, supporting public health, advancing gender equality, strengthening health systems, and promoting economic development. An additional 70 million women are projected to gain access by 2030. This rising awareness of the benefits and use of contraceptives is a significant factor propelling the hormonal contraceptives market.

Rising healthcare expenditure is expected to boost the growth of the hormonal contraceptives market in the coming years. Healthcare expenditure refers to the total financial resources spent by individuals, organizations, or governments on preventing, treating, and managing health conditions. Increasing expenditure is driven by advances in medical technology, as new diagnostic tools, treatments, and therapies often come at higher costs. Higher healthcare spending promotes the use of hormonal contraceptives by improving access, affordability, awareness, and supporting research and family planning programs. For example, in December 2024, according to the Centers for Medicare & Medicaid Services, a US-based agency administering Medicare and Medicaid programs, U.S. healthcare expenditures rose by 7.5% in 2023, reaching $4.9 trillion, or roughly $14,570 per person. Therefore, increasing healthcare expenditure is driving the expansion of the hormonal contraceptives market.

Leading companies in the hormonal contraceptives market are developing innovative products, such as nonprescription daily oral contraceptives, to improve accessibility and convenience for users. A nonprescription daily oral contraceptive is a birth control pill that can be purchased without a prescription from a healthcare provider. For instance, in July 2023, Perrigo Company PLC, a US-based manufacturer of private-label over-the-counter pharmaceuticals, received approval from the Food and Drug Administration (FDA) for Opill. Opill is the first nonprescription daily oral contraceptive, making effective birth control available to consumers without requiring a prescription or a healthcare appointment. This launch represents a significant milestone in reproductive health.

Major companies operating in the hormonal contraceptives market are Bayer AG, Merck & Co. Inc, Viatris, Gedeon Richter, AbbVie, Pfizer, Teva Pharmaceuticals, Mayne Pharma Group Limited, Lupin Limited, HLL Lifecare Limited, Amneal Pharmaceuticals, DKT International, Piramal Pharma Limited, Allergan, Afaxys Inc., Agile Therapeutic, Cipla Limited, Glenmark Pharmaceuticals, Novartis AG, Sun Pharmaceutical Industries Ltd., Apothecus Pharmaceutical Corporation, Famy Care, Mylan Laboratories

North America was the largest region in the hormonal contraceptives market share in 2025. Middle East is expected to be the fastest-growing region in the global hormonal contraceptives market analysis during the forecast period. The regions covered in the hormonal contraceptives market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the hormonal contraceptives market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The hormonal contraceptive market includes revenues earned by entities by blocking the release of eggs from the ovaries and thinning the lining of the uterus to prevent pregnancy. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Hormonal Contraceptives Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses hormonal contraceptives market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on end user analysis.
Benchmark performance against key competitors based on market share, innovation, and brand strength.
Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for hormonal contraceptives ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The hormonal contraceptives market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

Markets Covered:1) By Product: Pills; Injectable Birth Control; Vaginal Rings; Others
2) By End User: Hospitals; Homecare Settings; Gynecology Centers; Clinics; Ambulatory Surgical Centers
3) By Hormones: Progestin-Only; Combined Hormones
4) By Distribution Channel: Drug Stores; Gynecology Or Fertility Clinics; E-Commerce; Other Distribution Channels
Subsegments:
1) By Pills: Combined Oral Contraceptives (COCs); Progestin-Only Pills (POPs); Emergency Contraceptive Pills
2) By Injectable Birth Control: Depot Medroxyprogesterone Acetate (DMPA); Combination Injectable Contraceptives; Subdermal Implants
3) By Vaginal Rings: NuvaRing; Annovera; Other Hormonal Vaginal Rings
4) By Others: Transdermal Patches; Intrauterine Devices (IUDs) with Hormones; Hormonal Implants; Contraceptive Tablets For Men
Companies Mentioned: Bayer AG; Merck & Co. Inc; Viatris; Gedeon Richter; AbbVie; Pfizer; Teva Pharmaceuticals; Mayne Pharma Group Limited; Lupin Limited; HLL Lifecare Limited; Amneal Pharmaceuticals; DKT International; Piramal Pharma Limited; Allergan; Afaxys Inc.; Agile Therapeutic; Cipla Limited; Glenmark Pharmaceuticals; Novartis AG; Sun Pharmaceutical Industries Ltd.; Apothecus Pharmaceutical Corporation; Famy Care; Mylan Laboratories
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report
+ Excel Dashboard
Added Benefits
Bi-Annual Data Update
Customisation
Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Product Code: PH4THCON01_G26Q1

1. Executive Summary

1.1. Key Market Insights (2020-2035)
1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
1.3. Major Factors Driving the Market
1.4. Top Three Trends Shaping the Market

2. Hormonal Contraceptives Market Characteristics

2.1. Market Definition & Scope
2.2. Market Segmentations
2.3. Overview of Key Products and Services
2.4. Global Hormonal Contraceptives Market Attractiveness Scoring And Analysis
- 2.4.1. Overview of Market Attractiveness Framework
- 2.4.2. Quantitative Scoring Methodology
- 2.4.3. Factor-Wise Evaluation
Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation
2.4.5. Strategic Implications and Recommendations

3. Hormonal Contraceptives Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem
3.2. List Of Key Raw Materials, Resources & Suppliers
3.3. List Of Major Distributors and Channel Partners
3.4. List Of Major End Users

4. Global Hormonal Contraceptives Market Trends And Strategies

4.1. Key Technologies & Future Trends
- 4.1.1 Biotechnology, Genomics & Precision Medicine
- 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
- 4.1.3 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
- 4.1.4 Autonomous Systems, Robotics & Smart Mobility
- 4.1.5 Sustainability, Climate Tech & Circular Economy
4.2. Major Trends
- 4.2.1 Rise Of Hormone-Based Personalized Contraceptives
- 4.2.2 Increasing Awareness Of Reversible And Non-Reversible Options
- 4.2.3 Growth In Telemedicine And Online Contraceptive Services
- 4.2.4 Expansion Of Male Contraceptive Solutions
- 4.2.5 Focus On Contraceptives With Dual Protection Against Stds

5. Hormonal Contraceptives Market Analysis Of End Use Industries

5.1 Hospitals
5.2 Gynecology Centers
5.3 Clinics
5.4 Homecare Settings
5.5 Ambulatory Surgical Centers

6. Hormonal Contraceptives Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Hormonal Contraceptives Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Hormonal Contraceptives PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
7.2. Global Hormonal Contraceptives Market Size, Comparisons And Growth Rate Analysis
7.3. Global Hormonal Contraceptives Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
7.4. Global Hormonal Contraceptives Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Hormonal Contraceptives Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)
8.2. Methodology and Assumptions
8.3. Global Total Addressable Market (TAM) Estimation
8.4. TAM vs. Current Market Size Analysis
8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Hormonal Contraceptives Market Segmentation

9.1. Global Hormonal Contraceptives Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Pills, Injectable Birth Control, Vaginal Rings, Others
9.2. Global Hormonal Contraceptives Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Hospitals, Homecare Settings, Gynecology Centers, Clinics, Ambulatory Surgical Centers
9.3. Global Hormonal Contraceptives Market, Segmentation By Hormones, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Progestin-Only, Combined Hormones
9.4. Global Hormonal Contraceptives Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Drug Stores, Gynecology Or Fertility Clinics, E-Commerce, Other Distribution Channels
9.5. Global Hormonal Contraceptives Market, Sub-Segmentation Of Pills, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Combined Oral Contraceptives (COCs), Progestin-Only Pills (POPs), Emergency Contraceptive Pills
9.6. Global Hormonal Contraceptives Market, Sub-Segmentation Of Injectable Birth Control, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Depot Medroxyprogesterone Acetate (DMPA), Combination Injectable Contraceptives, Subdermal Implants
9.7. Global Hormonal Contraceptives Market, Sub-Segmentation Of Vaginal Rings, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
NuvaRing, Annovera, Other Hormonal Vaginal Rings
9.8. Global Hormonal Contraceptives Market, Sub-Segmentation Of Others, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Transdermal Patches, Intrauterine Devices (IUDs) with Hormones, Hormonal Implants, Contraceptive Tablets For Men

10. Hormonal Contraceptives Market Regional And Country Analysis

10.1. Global Hormonal Contraceptives Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
10.2. Global Hormonal Contraceptives Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Hormonal Contraceptives Market

11.1. Asia-Pacific Hormonal Contraceptives Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Hormonal Contraceptives Market, Segmentation By Product, Segmentation By End User, Segmentation By Hormones, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Hormonal Contraceptives Market

12.1. China Hormonal Contraceptives Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
12.2. China Hormonal Contraceptives Market, Segmentation By Product, Segmentation By End User, Segmentation By Hormones, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Hormonal Contraceptives Market

13.1. India Hormonal Contraceptives Market, Segmentation By Product, Segmentation By End User, Segmentation By Hormones, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Hormonal Contraceptives Market

14.1. Japan Hormonal Contraceptives Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
14.2. Japan Hormonal Contraceptives Market, Segmentation By Product, Segmentation By End User, Segmentation By Hormones, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Hormonal Contraceptives Market

15.1. Australia Hormonal Contraceptives Market, Segmentation By Product, Segmentation By End User, Segmentation By Hormones, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Hormonal Contraceptives Market

16.1. Indonesia Hormonal Contraceptives Market, Segmentation By Product, Segmentation By End User, Segmentation By Hormones, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Hormonal Contraceptives Market

17.1. South Korea Hormonal Contraceptives Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
17.2. South Korea Hormonal Contraceptives Market, Segmentation By Product, Segmentation By End User, Segmentation By Hormones, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Hormonal Contraceptives Market

18.1. Taiwan Hormonal Contraceptives Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
18.2. Taiwan Hormonal Contraceptives Market, Segmentation By Product, Segmentation By End User, Segmentation By Hormones, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Hormonal Contraceptives Market

19.1. South East Asia Hormonal Contraceptives Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
19.2. South East Asia Hormonal Contraceptives Market, Segmentation By Product, Segmentation By End User, Segmentation By Hormones, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Hormonal Contraceptives Market

20.1. Western Europe Hormonal Contraceptives Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
20.2. Western Europe Hormonal Contraceptives Market, Segmentation By Product, Segmentation By End User, Segmentation By Hormones, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Hormonal Contraceptives Market

21.1. UK Hormonal Contraceptives Market, Segmentation By Product, Segmentation By End User, Segmentation By Hormones, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Hormonal Contraceptives Market

22.1. Germany Hormonal Contraceptives Market, Segmentation By Product, Segmentation By End User, Segmentation By Hormones, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Hormonal Contraceptives Market

23.1. France Hormonal Contraceptives Market, Segmentation By Product, Segmentation By End User, Segmentation By Hormones, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Hormonal Contraceptives Market

24.1. Italy Hormonal Contraceptives Market, Segmentation By Product, Segmentation By End User, Segmentation By Hormones, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Hormonal Contraceptives Market

25.1. Spain Hormonal Contraceptives Market, Segmentation By Product, Segmentation By End User, Segmentation By Hormones, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Hormonal Contraceptives Market

26.1. Eastern Europe Hormonal Contraceptives Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
26.2. Eastern Europe Hormonal Contraceptives Market, Segmentation By Product, Segmentation By End User, Segmentation By Hormones, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Hormonal Contraceptives Market

27.1. Russia Hormonal Contraceptives Market, Segmentation By Product, Segmentation By End User, Segmentation By Hormones, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Hormonal Contraceptives Market

28.1. North America Hormonal Contraceptives Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
28.2. North America Hormonal Contraceptives Market, Segmentation By Product, Segmentation By End User, Segmentation By Hormones, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Hormonal Contraceptives Market

29.1. USA Hormonal Contraceptives Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
29.2. USA Hormonal Contraceptives Market, Segmentation By Product, Segmentation By End User, Segmentation By Hormones, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Hormonal Contraceptives Market

30.1. Canada Hormonal Contraceptives Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
30.2. Canada Hormonal Contraceptives Market, Segmentation By Product, Segmentation By End User, Segmentation By Hormones, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Hormonal Contraceptives Market

31.1. South America Hormonal Contraceptives Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
31.2. South America Hormonal Contraceptives Market, Segmentation By Product, Segmentation By End User, Segmentation By Hormones, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Hormonal Contraceptives Market

32.1. Brazil Hormonal Contraceptives Market, Segmentation By Product, Segmentation By End User, Segmentation By Hormones, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Hormonal Contraceptives Market

33.1. Middle East Hormonal Contraceptives Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
33.2. Middle East Hormonal Contraceptives Market, Segmentation By Product, Segmentation By End User, Segmentation By Hormones, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Hormonal Contraceptives Market

34.1. Africa Hormonal Contraceptives Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
34.2. Africa Hormonal Contraceptives Market, Segmentation By Product, Segmentation By End User, Segmentation By Hormones, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Hormonal Contraceptives Market Regulatory and Investment Landscape

36. Hormonal Contraceptives Market Competitive Landscape And Company Profiles

36.1. Hormonal Contraceptives Market Competitive Landscape And Market Share 2024
- 36.1.1. Top 10 Companies (Ranked by revenue/share)
36.2. Hormonal Contraceptives Market - Company Scoring Matrix
- 36.2.1. Market Revenues
- 36.2.2. Product Innovation Score
- 36.2.3. Brand Recognition
36.3. Hormonal Contraceptives Market Company Profiles
- 36.3.1. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
- 36.3.2. Merck & Co. Inc Overview, Products and Services, Strategy and Financial Analysis
- 36.3.3. Viatris Overview, Products and Services, Strategy and Financial Analysis
- 36.3.4. Gedeon Richter Overview, Products and Services, Strategy and Financial Analysis
- 36.3.5. AbbVie Overview, Products and Services, Strategy and Financial Analysis

37. Hormonal Contraceptives Market Other Major And Innovative Companies

Pfizer, Teva Pharmaceuticals, Mayne Pharma Group Limited, Lupin Limited, HLL Lifecare Limited, Amneal Pharmaceuticals, DKT International, Piramal Pharma Limited, Allergan, Afaxys Inc., Agile Therapeutic, Cipla Limited, Glenmark Pharmaceuticals, Novartis AG, Sun Pharmaceutical Industries Ltd.

38. Global Hormonal Contraceptives Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Hormonal Contraceptives Market

40. Hormonal Contraceptives Market High Potential Countries, Segments and Strategies

40.1 Hormonal Contraceptives Market In 2030 - Countries Offering Most New Opportunities
40.2 Hormonal Contraceptives Market In 2030 - Segments Offering Most New Opportunities
40.3 Hormonal Contraceptives Market In 2030 - Growth Strategies
- 40.3.1 Market Trend Based Strategies
- 40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations
41.2. Currencies
41.3. Historic And Forecast Inflation Rates
41.4. Research Inquiries
41.5. The Business Research Company
41.6. Copyright And Disclaimer